Skip to main content

Page of 24
and
  1. Article

    Open Access

    Phase II study of novel orally PI3Kα/δ inhibitor TQ-B3525 in relapsed and/or refractory follicular lymphoma

    This registration study assessed clinical outcomes of TQ-B3525, the dual phosphatidylinositol-3-kinase (PI3K) α/δ inhibitor, in relapsed and/or refractory follicular lymphoma (R/R FL). This phase II study (Cli...

    Huaqing Wang, Jifeng Feng, Yanyan Liu in Signal Transduction and Targeted Therapy (2024)

  2. Article

    Open Access

    Targeting PCSK9 to upregulate MHC-II on the surface of tumor cells in tumor immunotherapy

    Proprotein convertase subtilisin/kexin type 9 (PCSK9), the last member of the proprotein convertase family, functions as a classic regulator of low-density lipoprotein (LDL) by interacting with low-density lip...

    Hanbing Wang, **n Zhang, Yipeng Zhang, Tao Shi, Yue Zhang, Xueru Song in BMC Cancer (2024)

  3. Article

    Open Access

    Real-world advantage and challenge of post-autologous stem cell transplantation MRD negativity in high-risk patients with double-hit multiple myeloma

    Autologous stem-cell transplantation (ASCT) remains a beneficial approach for patients with newly diagnosed multiple myeloma (NDMM) in the age of novel therapeutic agents. Nevertheless, limited real-world data...

    Yi Tao, Shiwei **, Dan Yang, Mengmeng Pan, Wanyan Ouyang, Yuanfang Liu in BMC Cancer (2024)

  4. Article

    Open Access

    Mex-3 RNA binding family member A (MEX3A)/circMPP6 complex promotes colorectal cancer progression by inhibiting autophagy

    RNA-binding proteins (RBPs)-RNA networks have contributed to cancer development. Circular RNAs (circRNAs) are considered as protein recruiters; nevertheless, the patterns of circRNA-protein interactions in col...

    Ri-**n Chen, Shui-Dan Xu, Min-Hua Deng in Signal Transduction and Targeted Therapy (2024)

  5. Article

    Open Access

    Transarterial chemoembolization with molecular targeted therapies plus camrelizumab for recurrent hepatocellular carcinoma

    The safety and efficacy of transarterial chemoembolization plus molecular targeted therapy (MTT) combined with immune checkpoint inhibitors (ICIs) in primary liver cancer have been demonstrated. However, the e...

    Changlong Hou, Baizhu **ong, Lei Zhou, Yipeng Fei, Changgao Shi, **anhai Zhu in BMC Cancer (2024)

  6. Article

    Open Access

    TGF-β signaling in health, disease, and therapeutics

    Transforming growth factor (TGF)-β is a multifunctional cytokine expressed by almost every tissue and cell type. The signal transduction of TGF-β can stimulate diverse cellular responses and is particularly cr...

    Ziqin Deng, Tao Fan, Chu **ao, He Tian in Signal Transduction and Targeted Therapy (2024)

  7. Article

    Open Access

    Is low-dose computed tomography for lung cancer screening conveniently accessible in China? A spatial analysis based on cross-sectional survey

    Regular Low-Dose Computed Tomography (LDCT) for lung cancer high-risk population has been proved to improve health outcomes and relieve disease burden efficiently for both individual and society. With geograph...

    Jay Pan, Jianjian Wang, Wenjuan Tao, Chaohui Wang, **aojun Lin, **uli Wang in BMC Cancer (2024)

  8. Article

    Open Access

    Fully semantic segmentation for rectal cancer based on post-nCRT MRl modality and deep learning framework

    Rectal tumor segmentation on post neoadjuvant chemoradiotherapy (nCRT) magnetic resonance imaging (MRI) has great significance for tumor measurement, radiomics analysis, treatment planning, and operative strat...

    Shaojun **a, Qingyang Li, Hai-Tao Zhu, **ao-Yan Zhang, Yan-Jie Shi, Ding Yang in BMC Cancer (2024)

  9. Article

    Open Access

    Chemotherapy re-use versus anti-angiogenic monotherapy as the third-line treatment of patients with metastatic colorectal cancer: a real-world cohort study

    There are various recommendations for third-line treatment in mCRC, however, there is no consensus on who is more suitable for particular strategy. Chemotherapy re-use in third-line setting is a common option ...

    **g**g Duan, Lila Zhu, Yinghui Shi, Weixue Wang, Tongtong Wang, Tao Ning in BMC Cancer (2024)

  10. Article

    Open Access

    Adaptive Darwinian off-target resistance mechanisms to selective RET inhibition in RET driven cancer

    Patients treated with RET protein tyrosine kinase inhibitors (TKIs) selpercatinib or pralsetinib develop RET TKI resistance by secondary RET mutations or alterative oncogenes, of which alterative oncogenes pos...

    Vivek Subbiah, Mohamed A. Gouda, J. Bryan Iorgulescu, Ramona Dadu in npj Precision Oncology (2024)

  11. Article

    Open Access

    Tertiary lymphoid structures predict survival and response to neoadjuvant therapy in locally advanced rectal cancer

    Tertiary lymphoid structure (TLS) contributes to the anti-tumor immune response, and predicts the prognosis of colorectal cancer patients. However, the potential impact of TLS in sha** the immune status of r...

    Qianyu Wang, Wentao Zhong, **aofei Shen, Zechen Hao, Meng Wan in npj Precision Oncology (2024)

  12. Article

    Open Access

    Advanced gastrointestinal stromal tumor: reliable classification of imatinib plasma trough concentration via machine learning

    Patients with advanced gastrointestinal stromal tumors (GISTs) exhibiting an imatinib plasma trough concentration (IM Cmin) under 1100 ng/ml may show a reduced drug response rate, leading to the suggestion of mon...

    Pan Ran, Tao Tan, **** Li, Hao Yang, Juan Li, Jun Zhang in BMC Cancer (2024)

  13. Article

    Open Access

    Combined score based on plasma fibrinogen and platelet-lymphocyte ratio as a prognostic biomarker in esophageal squamous cell carcinoma

    Increasing evidence has showed that inflammatory biomarkers, including neutrophil to lymphocyte ratio (NLR), platelet to lymphocyte ratio (PLR) and fibrinogen can be used as predictors in the prognosis of esop...

    Yuchong Yang, Hui Tan, Yao Lu, Jipeng Mei, Mengqi Zhang, Ming Bai, **a Wang in BMC Cancer (2024)

  14. Article

    Open Access

    Utility and predictive value of the CRAFITY score in advanced hepatocellular carcinoma treated with transarterial chemoembolization plus tyrosine kinase inhibitors and PD-1 inhibitor

    The prognostic significance of the CRAFITY score (CRP and AFP in ImmunoTherapY) has been demonstrated in hepatocellular carcinoma (HCC) patients receiving immunotherapy. The purpose of this study was to investiga...

    Lijie Zhang, Tao Sun, Bo Sun, Kailu Zhang, Yuting Zheng, Na Li, Lei Chen in BMC Cancer (2024)

  15. Article

    Open Access

    High expression of TBRG4 in relation to unfavorable outcome and cell ferroptosis in hepatocellular carcinoma

    Hepatocellular carcinoma (HCC) is the most common type of malignant liver tumor with poor prognosis. In this study, we investigated the expression of transforming growth factor beta regulator 4 (TBRG4) in HCC ...

    Shanchun Tao, Di Cui, Huimin Cheng, **aofei Liu, Zhaobin Jiang, Hongwei Chen in BMC Cancer (2024)

  16. Article

    Open Access

    LncRNA RPARP-AS1 promotes the progression of osteosarcoma cells through regulating lipid metabolism

    Osteosarcoma (OS) is a highly malignant tumor, and its dysregulated lipid metabolism is associated with tumorigenesis and unfavorable prognosis. Interestingly, long noncoding RNAs (lncRNAs) have emerged as piv...

    Feng Cai, Luhua Liu, Yuan Bo, Wen**g Yan, Xuchang Tao, Yuanxiang Peng in BMC Cancer (2024)

  17. Article

    Open Access

    Alternative splicing and related RNA binding proteins in human health and disease

    Alternative splicing (AS) serves as a pivotal mechanism in transcriptional regulation, engendering transcript diversity, and modifications in protein structure and functionality. Across varying tissues, develo...

    Yining Tao, Qi Zhang, Haoyu Wang, **yu Yang in Signal Transduction and Targeted Therapy (2024)

  18. Article

    Open Access

    A system review of central nervous system tumors on children in China: epidemiology and clinical characteristics

    Central nervous system (CNS) tumors are the most common solid tumors in children and the leading cause of cancer-related death in the latter. Currently, the incidence rate exceeds that of leukemia and ranks fi...

    Bing Yao, Hongying Wang, **aomei Wu, Chenyu Wang, Tao Tang, Wenxiu An, Bo Zhu in BMC Cancer (2024)

  19. Article

    Open Access

    Long-term outcomes with HLX01 (HanliKang®), a rituximab biosimilar, in previously untreated patients with diffuse large B-cell lymphoma: 5-year follow-up results of the phase 3 HLX01-NHL03 study

    HLX01 (HanliKang®) is a rituximab biosimilar that showed bioequivalence to reference rituximab in untreated CD20-positive diffuse large B-cell lymphoma (DLBCL) in the phase 3 HLX01-NHL03 study. Here, we report th...

    Yan Qin, Yong** Song, Dong Wang, Ou Bai, Jifeng Feng, **uhua Sun, Lihua Qiu in BMC Cancer (2024)

  20. Article

    Open Access

    Red blood cell distribution width is associated with sarcopenia risk in early-stage non-small cell lung cancer

    Sarcopenia has received increasing attention in non-small cell lung cancer (NSCLC). Red blood cell distribution width (RDW) is a significant component of the complete blood count and indicates the heterogeneit...

    Qing-chun Jia, Ling Qin, Ye Niu, Le Liu, **-** Liu, Shi-di Miao in BMC Cancer (2024)

Page of 24